1. Home
  2. STLD vs BNTX Comparison

STLD vs BNTX Comparison

Compare STLD & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Steel Dynamics Inc.

STLD

Steel Dynamics Inc.

HOLD

Current Price

$167.64

Market Cap

20.8B

Sector

Industrials

ML Signal

HOLD

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$103.58

Market Cap

23.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STLD
BNTX
Founded
1993
2008
Country
United States
Germany
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.8B
23.0B
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
STLD
BNTX
Price
$167.64
$103.58
Analyst Decision
Buy
Buy
Analyst Count
9
11
Target Price
$168.56
$137.40
AVG Volume (30 Days)
1.2M
962.0K
Earning Date
10-20-2025
11-03-2025
Dividend Yield
1.19%
N/A
EPS Growth
N/A
N/A
EPS
7.51
N/A
Revenue
$17,634,671,000.00
$3,698,814,972.00
Revenue This Year
$7.13
N/A
Revenue Next Year
$8.76
$9.49
P/E Ratio
$22.41
N/A
Revenue Growth
N/A
3.70
52 Week Low
$103.17
$81.20
52 Week High
$168.36
$129.27

Technical Indicators

Market Signals
Indicator
STLD
BNTX
Relative Strength Index (RSI) 69.50 51.10
Support Level $152.54 $94.00
Resistance Level $159.73 $113.39
Average True Range (ATR) 4.67 3.48
MACD 0.93 -0.20
Stochastic Oscillator 98.58 46.42

Price Performance

Historical Comparison
STLD
BNTX

About STLD Steel Dynamics Inc.

Steel Dynamics Inc operates as a domestic steel producer and metal recycler in the United States. The company's product portfolio comprises hot rolled sheet, hot rolled plate, painted sheet products, cold rolled sheet, and others. Its reportable segments are steel operations, metals recycling operations, steel fabrication operations, and aluminum operations. Maximum revenue is generated from its steel operations segment, which consists of manufacturing various steel products and numerous coating operations. Its primary sources of revenue are currently from the manufacture and sale of steel products, the processing and sale of recycled ferrous and nonferrous metals, and the fabrication and sale of steel joists and deck products.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: